Engineered troponin C constructs correct disease-related cardiac myofilament calcium sensitivity.
Ontology highlight
ABSTRACT: Aberrant myofilament Ca(2+) sensitivity is commonly observed with multiple cardiac diseases, especially familial cardiomyopathies. Although the etiology of the cardiomyopathies remains unclear, improving cardiac muscle Ca(2+) sensitivity through either pharmacological or genetic approaches shows promise of alleviating the disease-related symptoms. Due to its central role as the Ca(2+) sensor for cardiac muscle contraction, troponin C (TnC) stands out as an obvious and versatile target to reset disease-associated myofilament Ca(2+) sensitivity back to normal. To test the hypothesis that aberrant myofilament Ca(2+) sensitivity and its related function can be corrected through rationally engineered TnC constructs, three thin filament protein modifications representing different proteins (trop
SUBMITTER: Liu B
PROVIDER: S-EPMC3370186 | biostudies-literature | 2012 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA